Plain-English translation of NCT07224269 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
Researchers at the University of Iowa are testing whether terazosin, a medication normally used to treat high blood pressure, might help people with ALS by boosting the energy levels in their cells. ALS is a disease where nerve cells gradually break down, and scientists think problems with cell energy might play a role. This small pilot study will help researchers understand whether this medication is safe and whether it affects how cells produce and use energy.
People with ALS may have problems with how their cells create and use energy, which could be contributing to the disease. Researchers want to know if this medication, which is already used safely for other conditions, might help reverse these energy problems and guide future treatments for ALS.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to take either terazosin or a placebo (inactive pill) daily at a dose of 5 milligrams. Over the course of the study, you'll visit the research center for blood draws, breathing tests, body scans (PET imaging), questionnaires, and physical exams to check your safety and measure how the medication affects your cell energy levels. The researchers will carefully monitor you for any side effects.
AI-generated summary from trial data ยท Aug 17, 2026 ยท Not medical advice
United States